Pin Chen

Pin Chen

National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei, 430070, China

Biography
Dr. Ping Chen, Ph.D. Co-Founder of PharmaResources (Shanghai) Co., Ltd. and serves as its Chairman and Chief Executive Officer. Dr. Chen has over 17 years of experience in Medicinal Chemistry at Bristol-Myers Squibb. He is a primary inventor on Dasatinib (SprycelTM), a marketed drug targeting BCR-ABL/Src kinases for the treatment of Chronic Myelogenous Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (ALL).
Research Interest
Immunology, Vaccines, vaccination, immunization, vaccinology, cell biology